Autophagic blockade potentiates anlotinib-mediated ferroptosis in anaplastic thyroid cancer
Endocrine-Related Cancer · 2023
DOI: 10.1530/erc-23-0036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine-Related Cancer, 2023. Verfasst von Jiajun Wu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Department, Bengbu Medical College, Bengbu, Anhui, China. Hauptthemen laut MEDLINE: Thyroid Carcinoma, Anaplastic, Ferroptosis, Thyroid Neoplasms. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Anlotinib-mediated angiogenic remodeling was delineated in various tumors. Meanwhile, we previously showed that anlotinib inhibited tumor angiogenesis in anaplastic thyroid cancer (ATC). However, the potential role of anlotinib on cell lethality in ATC remains an enigma. Herein, we found that anlotinib inhibited the viability, proliferation, and migration of KHM-5M, C643, and 8505C cells in a dose-dependently manner. Under anlotinib treatment, PANoptosis (pyroptosis, apoptosis, and necroptosis) markers were not changed; however, ferroptosis targets (transferrin, HO-1, FTH1, FTL, and GPX4) were significantly downregulated. ROS levels also increased in a concentration-dependent manner after anlotinib treatment in KHM-5M, C643, and 8505C cells. In addition, protective autophagy was activated in response to anlotinib, and autophagic blockade potentiated anlotinib-mediated ferroptosis and antitumor effects in vitro and in vivo . Our new discovery identified autophagy-ferroptosis signaling pathway which provides mechanistic insight into anlotinib-mediated cell death, and synergistic combination therapy may help develop new ATC treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Department, Bengbu Medical College, Bengbu, Anhui, China.
- Otolaryngology & Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, People's Rep…
- Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, Hangzhou, Zhejiang, People's Republic of China.
- Clinical Research Center for Cancer of Zhejiang Province, Hangzhou, Zhejiang, People's Republic of China.
- Department of Thyroid and Breast Surgery, Zhejiang Provincial People's Hospital Bijie Hospital, Bijie, Guizhou, China.
- Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID-Profile: Juyong Liang, Tian Lv, Minghua Ge, Jiafeng Wang
Zitieren
APA
Wu, J., Liang, J., Liu, R., Lv, T., Fu, K., Jiang, L., Ma, W., Pan, Y., Tan, Z., Liu, Q., Qiu, W., Ge, M., & Wang, J. (2023). Autophagic blockade potentiates anlotinib-mediated ferroptosis in anaplastic thyroid cancer. Endocrine-Related Cancer. https://doi.org/10.1530/erc-23-0036
Vancouver
Wu J, Liang J, Liu R, Lv T, Fu K, Jiang L, et al. Autophagic blockade potentiates anlotinib-mediated ferroptosis in anaplastic thyroid cancer. Endocrine-Related Cancer. 2023. doi:10.1530/erc-23-0036
BibTeX
@article{Wu2023,
author = {Wu, Jiajun and Liang, Juyong and Liu, Ruiqi and Lv, Tian and Fu, Kangyin and Jiang, Liehao and Ma, Wenli and Pan, Yan and Tan, Zhuo and Liu, Qing and Qiu, Weihua and Ge, Minghua and Wang, Jiafeng},
title = {Autophagic blockade potentiates anlotinib-mediated ferroptosis in anaplastic thyroid cancer},
journal = {Endocrine-Related Cancer},
year = {2023},
doi = {10.1530/erc-23-0036}
}
EUVIMED